Quality of Life Outcomes from a Dose-per-Fraction Escalation Trial of Hypofractionation in Prostate Cancer

OBJECTIVE: This multi-institutional phase I/II trial explored patient-assessed tolerance of increasingly hypofractionated (HPFX) radiation for low/intermediate risk prostate cancer. METHODS: 347 patients enrolled from 2002–2010. Three increasing dose-per-fraction schedules of 64.7 Gy/22 fx, 58.08 Gy...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Radiother Oncol
Autori principali: Brower, Jeffrey V, Forman, Jeffrey D, Kupelian, Patrick A, Petereit, Daniel G, Gondi, Vinai, Lawton, Colleen A, Anger, Nick, Saha, Sandeep, Chappell, Rick, Ritter, Mark A
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2016
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4764419/
https://ncbi.nlm.nih.gov/pubmed/26755165
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.radonc.2015.12.018
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi